Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Myristoylated alanine-rich C-kinase substrate (MARCKS) is a membrane-associated, intrinsically disordered protein encoded by the MARCKS gene. It is a major cellular substrate for protein kinase C (PKC), with key roles in modulating the actin cytoskeleton, regulating cell shape, motility, secretion/exocytosis processes, phagocytosis, membrane trafficking, neural development/plasticity, and immune responses. MARCKS binds to actin filaments via its phosphorylation site domain when unphosphorylated but dissociates from both actin and membranes upon phosphorylation by PKC or binding to calcium-calmodulin. This dynamic localization acts as an "electrostatic switch" controlling its function between membrane-bound and cytoplasmic states. It sequesters phosphatidylinositol 4,5-bisphosphate (PIP2) at lipid rafts in quiescent cells—a process reversed by PKC activation—thereby influencing exocytosis. MARCKS has been implicated in various physiological processes including embryonic development and inflammation; it also plays roles in disease contexts such as cancer progression/invasion and neuropsychiatric disorders
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myristoylated alanine-rich C-kinase substrate (MARCKS).